Moore JP - Search Results

1

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.

Healey D, Dianda L, Moore JP, McDougal JS, Moore MJ, Estess P, Buck D, Kwong PD, Beverley PC, Sattentau QJ. Healey D, et al. Among authors: moore jp, moore mj. J Exp Med. 1990 Oct 1;172(4):1233-42. doi: 10.1084/jem.172.4.1233. J Exp Med. 1990. PMID: 1698911 Free PMC article.

2

CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro.

Moore JP, Simpson G, McKeating JA, Burakoff SJ, Schreiber SL, Weiss RA. Moore JP, et al. Virology. 1992 Jun;188(2):537-44. doi: 10.1016/0042-6822(92)90508-m. Virology. 1992. PMID: 1316672

3

Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site.

McKeating JA, Moore JP, Ferguson M, Marsden HS, Graham S, Almond JW, Evans DJ, Weiss RA. McKeating JA, et al. Among authors: moore jp. AIDS Res Hum Retroviruses. 1992 Apr;8(4):451-9. doi: 10.1089/aid.1992.8.451. AIDS Res Hum Retroviruses. 1992. PMID: 1376134

4

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.

Moore JP, Sattentau QJ, Klasse PJ, Burkly LC. Moore JP, et al. J Virol. 1992 Aug;66(8):4784-93. doi: 10.1128/JVI.66.8.4784-4793.1992. J Virol. 1992. PMID: 1378510 Free PMC article.

5

Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.

Sattentau QJ, Moore JP. Sattentau QJ, et al. Among authors: moore jp. J Exp Med. 1991 Aug 1;174(2):407-15. doi: 10.1084/jem.174.2.407. J Exp Med. 1991. PMID: 1713252 Free PMC article.

6

Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.

Cordell J, Moore JP, Dean CJ, Klasse PJ, Weiss RA, McKeating JA. Cordell J, et al. Among authors: moore jp. Virology. 1991 Nov;185(1):72-9. doi: 10.1016/0042-6822(91)90755-z. Virology. 1991. PMID: 1718090

7

Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.

Moore JP, McKeating JA, Huang YX, Ashkenazi A, Ho DD. Moore JP, et al. J Virol. 1992 Jan;66(1):235-43. doi: 10.1128/JVI.66.1.235-243.1992. J Virol. 1992. PMID: 1727487 Free PMC article.

8

Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.

Moore JP, McKeating JA, Norton WA, Sattentau QJ. Moore JP, et al. J Virol. 1991 Mar;65(3):1133-40. doi: 10.1128/JVI.65.3.1133-1140.1991. J Virol. 1991. PMID: 1995942 Free PMC article.

9

Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies.

Moore JP, Sattentau QJ, Clapham PR. Moore JP, et al. AIDS Res Hum Retroviruses. 1990 Nov;6(11):1273-9. doi: 10.1089/aid.1990.6.1273. AIDS Res Hum Retroviruses. 1990. PMID: 2078408

10

Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.

Moore JP, McKeating JA, Jones IM, Stephens PE, Clements G, Thomson S, Weiss RA. Moore JP, et al. AIDS. 1990 Apr;4(4):307-15. doi: 10.1097/00002030-199004000-00004. AIDS. 1990. PMID: 2190605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters